Company intelligence / Profile preview

Meridian Life Science

Cincinnati, Ohio, USAmeridianbioscience.com ↗

Ownership: Private
Employees: ~304
Development stage: Commercial

Overview

Meridian Life Science supplies critical raw materials—antibodies, antigens, recombinant proteins, PCR/qPCR enzymes and mixes—for diagnostic assay development. Their products are validated in FDA-, CE-, TGA-, ANVISA-approved commercial assays worldwide. They recently launched lyophilized NGS library prep kits and continue to expand their portfolio with innovative molecular tools.

Therapeutic areas: OncologyEndocrinologyImmunologyOtherCardiovascularInfectious Diseases
Modalities: Recombinant proteinMonoclonal antibodyPolyclonal antibodyEnzymeNucleotide reagentsSmall moleculeMolecular biology reagents
Industry: Chemicals & Materials

Partnerships

Supplies OEM/custom bulk reagents to major IVD manufacturers globally.

Beyond the preview

Go deeper on Meridian Life Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meridian Life Science.

Explore the full profile